ReviewAntioxidants (Basel, Switzerland)2026
Dates, Polyunsaturated Fatty Acids, Dietary Fiber, and Probiotics as Potential Complementary Modulators of Gut Microbiota and Oxidative Stress: An Integrative Review.
Review in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This integrative review examines the potential of dates, omega-3 (ω-3) and omega-6 (ω-6) polyunsaturated fatty acids (PUFAs), dietary fibers (DFs), and probiotic bacteria to support gut health through complementary nutritional pathways. The literature was searched in PubMed, Web of Science, Scopus, and Google Scholar for English-language studies published through June 2026. Dates contain fermentable substrates, including DFs and non-digestible oligosaccharides, that can serve as growth substrates for beneficial gut microbes. However, the whole fruit has not been formally established as a prebiotic under current consensus definitions. ω-3 and ω-6 fatty acids contribute to membrane integrity, eicosanoid synthesis, immune regulation, and inflammatory signaling, with effects influenced by dietary balance. DFs support gastrointestinal function, glycemic regulation, lipid metabolism, and colonic fermentation, including short-chain fatty acid (SCFA) production, whereas probiotics may exert strain-specific effects on microbial balance, barrier function, immune responses, and host metabolism. Together, these components may influence gut microbiota, oxidative stress, inflammation, and metabolic homeostasis. However, the evidence is heterogeneous, combined interventions are scarce, and several proposed effects rely mainly on preclinical studies or surrogate human outcomes. Thus, potential collaborative effects and disease-prevention implications remain unconfirmed. Well-designed human trials using standardized preparations, realistic intake levels, and clinically relevant outcomes are needed to clarify their combined effects.
Indexed as
Identifiers
42792136What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.